See how we bring together global data assets, AI-powered analytic solutions, and industry-leading healthcare expertise
In the competitive landscape of rare disease treatment, timely and effective engagement with healthcare providers (HCPs) is essential. Our latest case study demonstrates how IQVIA’s Integrated Field Alerts can significantly improve field engagement and optimize product adoption.
Marketing a drug for an ultra-rare disease presents unique challenges, especially with the introduction of new competitors. Identifying and engaging relevant HCPs quickly and before treatment decisions are made is crucial for optimizing product adoption.
IQVIA designed an integrated field alerts program that leverages deterministic HCP digital behavioral insights from IQVIA’s Audience Identity Manager® XR (AIM XR) technology. This enhanced the existing alerts program by providing more precise and actionable HCP insights to pair with clinical insights.
The integrated HCP alert program delivered several key benefits:
We'd love to show you how AI and Machine Learning can help you find the right patients, the right HCPs, and develop patient journey insights with precision and speed.
Just send us a message and we'll connect you to a dedicated expert who you can give you a demonstration, customized to your goals and needs.
See how an IQVIA client boosted predictive precision of patients by 8% with enriched data
Identifying the right HCPs and patients produced a 5x greater rate of treatment transition vs previous methods
See how we bring together global data assets, AI-powered analytic solutions, and industry-leading healthcare expertise
Quickly identify opportunity patients and easily discover high value physicians